245 related articles for article (PubMed ID: 3460627)
1. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology].
Tomonaga M
Rinsho Byori; 2005 Jan; 53(1):54-60. PubMed ID: 15724491
[TBL] [Abstract][Full Text] [Related]
3. Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented apoptotic neutrophil?
Shetty VT; Mundle SD; Raza A
Blood; 2001 Aug; 98(4):1273-5. PubMed ID: 11510471
[No Abstract] [Full Text] [Related]
4. Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.
Li X; Wu L; Ying S; Chang C; Pu Q
Int J Hematol; 2008 Mar; 87(2):176-183. PubMed ID: 18256784
[TBL] [Abstract][Full Text] [Related]
5. Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome.
Sasada K; Yamamoto N; Masuda H; Tanaka Y; Ishihara A; Takamatsu Y; Yatomi Y; Katsuda W; Sato I; Matsui H;
Leuk Res; 2018 Jun; 69():54-59. PubMed ID: 29656215
[TBL] [Abstract][Full Text] [Related]
6. Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly.
Wang E; Boswell E; Siddiqi I; Lu CM; Sebastian S; Rehder C; Huang Q
Am J Clin Pathol; 2011 Feb; 135(2):291-303. PubMed ID: 21228370
[TBL] [Abstract][Full Text] [Related]
7. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome.
Chiang M; Fleming M
Am J Dermatopathol; 2007 Jun; 29(3):293-5. PubMed ID: 17519630
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndrome in a patient with familial Pelger-Huet anomaly].
Hiraga H; Yabe H; Nagai K; Nakayama S
Rinsho Ketsueki; 1991 Nov; 32(11):1453-7. PubMed ID: 1758052
[TBL] [Abstract][Full Text] [Related]
9. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
10. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
11. Pseudo-Pelger-Huët anomaly in a patient on tacrolimus.
Joneja U; Uppal G
Blood; 2015 Jul; 126(2):277. PubMed ID: 26371350
[No Abstract] [Full Text] [Related]
12. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
Laï JL; Zandecki M; Fenaux P; Le Baron F; Bauters F; Cosson A; Deminatti M
Cancer Genet Cytogenet; 1990 Jun; 46(2):173-83. PubMed ID: 2340488
[TBL] [Abstract][Full Text] [Related]
13. Historical perspective and clinical implications of the Pelger-Hüet cell.
Cunningham JM; Patnaik MM; Hammerschmidt DE; Vercellotti GM
Am J Hematol; 2009 Feb; 84(2):116-9. PubMed ID: 19021122
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.
Xiong B; Tang ZH; Zou P; Yue QF; Chen WX; Liu XY
Acta Haematol; 2014; 131(2):126-32. PubMed ID: 24158033
[TBL] [Abstract][Full Text] [Related]
15. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
18. Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype.
Valent P; Fonatsch C; Stindl R; Schwarzinger I; Haas OA; Sperr WR; Geissler K; Lechner K
Leuk Res; 2004 Jun; 28(6):651-5. PubMed ID: 15120944
[TBL] [Abstract][Full Text] [Related]
19. Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.
Goasguen JE; Bennett JM; Bain BJ; Brunning RD; Vallespí MT; Tomonaga M; Zini G; Renault A;
Leuk Res; 2016 Jun; 45():75-81. PubMed ID: 27107657
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome].
Li J; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):657-61. PubMed ID: 23815917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
